Pediatric Mortality in a Rural Tertiary Care Center in Liberia

Carmelle Tsai1, Camila B Walters2, John Sampson3

  • 1Department of Pediatrics, University of Texas at Southwestern, Dallas, Texas 75390, USA. carmelle.tsai@gmail.com.

Insights

Pediatric mortality in rural Liberia was primarily due to neonatal sepsis and malaria. These findings highlight key areas for intervention to reduce child deaths in post-war West Africa.

Area of Science:

  • Global Health
  • Pediatrics
  • Epidemiology

Background:

  • Liberia, a low-income West African nation, has experienced significant challenges including civil war and the Ebola epidemic.
  • Limited data exists on current child health trends in rural Liberia, particularly in the post-war and pre-Ebola periods.

Purpose of the Study:

  • To investigate pediatric mortality trends in a rural tertiary care center in Liberia.
  • To identify the primary causes of death among children admitted in 2013, a decade after the civil war.

Main Methods:

  • A retrospective chart review was conducted for all pediatric admissions between January and December 2013.
  • Data on patient demographics, diagnoses, and outcomes were analyzed to determine mortality rates and causes.

Main Results:

  • Fifty pediatric deaths occurred, representing 5.4% of 920 total pediatric admissions.
  • The leading cause of neonatal death was sepsis; malaria was the leading cause of death for children under five.
  • A significant majority (82.0%) of deaths were in children under five years of age.

Conclusions:

  • Pediatric mortality in this rural Liberian setting is comparable to earlier post-war data and lower than immediate post-war figures.
  • Neonatal sepsis and malaria are critical contributors to pediatric mortality, necessitating focused public health interventions.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
405
Specialized Care Centers and Settings-II01:30

Specialized Care Centers and Settings-II

Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
1.3K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
625
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
304
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
583